BiotechTube
Home/Selonterra/Shaheen Sheik-Sadhal, JD
SS

Shaheen Sheik-Sadhal, JD

General Counsel

Selonterra

Therapeutic Areas

Alzheimer's DiseaseParkinson's DiseaseALSFrontotemporal Dementia

Selonterra Pipeline

DrugIndicationPhase
Alzheimer's Disease ProgramAlzheimer's Disease (APOE4)Preclinical
Parkinson's Disease ProgramParkinson's Disease (SNCA A53T, LRRK2 G2019S)Preclinical
ALS/FTD ProgramALS/Frontotemporal Dementia (C9orf72)Research
Familial Alzheimer's ProgramAlzheimer's Disease (Familial mutations)Research

Leadership Team at Selonterra

AU
Anne Urfer-Buchwalder, PhD
Founder and President
RU
Roman Urfer, PhD
Founder and Chief Executive Officer
KN
Karoly Nikolich, PhD
Director
PP
Paolo Pevarello, PhD
Medicinal Chemistry Advisor
TD
Tom Digby, JD
Intellectual Property Strategy
View full Selonterra profile